← FDA Drug Approvals (Drugs@FDA)
IOFLUPANE I-123
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CURIUM · Approved 2022-03-30
Drug application
- FDA Application #
ANDA213792- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- IOFLUPANE I-123
- Generic name
- IOFLUPANE I-123
- Active ingredients
- IOFLUPANE I-123
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- CURIUM
- Manufacturer
- Curium US LLC
- First approval
- 2022-03-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown